Assessing accuracy of Weibull shape parameter estimate from historical studies for subsequent sample size calculation in clinical trials with time-to-event outcome-Reference-Cited by-同舟云学术

Assessing accuracy of Weibull shape parameter estimate from historical studies for subsequent sample size calculation in clinical trials with time-to-event outcome

Published:2020-03 Issue: Volume:17 Page:100548
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Phadnis Milind A.,Sharma Palash,Thewarapperuma Nadeesha,Chalise Prabhakar

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference23 articles.

1. Comparing survival of a sample to that of a standard population;Finkelstein;J. Natl. Cancer Inst.,2003

2. Phase II clinical trials with time-to-event endpoints: optimal two-stage designs with one-sample log-rank test;Kwak;Stat. Med.,2014

3. Randomized Phase II Cancer Clinical Trial;Jung,2013

4. Phase II cancer clinical trials with a one-sample log-rabk test and its corrections based on the Edgeworth expansion;Sun;Contemp. Clin. Trials,2011

5. Sample size calculation for the one-sample log-rank test;Wu;Pharmaceut. Stat.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sample size considerations for single-arm clinical trials with time-to-event endpoint using the gamma distribution;Contemporary Clinical Trials Communications;2024-10

2. Sample Size Reestimation in Stochastic Curtailment Tests With Time‐to‐Events Outcome in the Case of Nonproportional Hazards Utilizing Two Weibull Distributions With Unknown Shape Parameters;Pharmaceutical Statistics;2024-08-18

3. Group sequential design for time-to-event outcome with non-proportional hazards using the concept of relative time utilizing two different Weibull distributions;Contemporary Clinical Trials Communications;2024-08

4. Sample Size Considerations for Single-Arm Clinical Trials with Time-to-Event Endpoint Using the Gamma Distribution;2024

5. Stochastic curtailment tests for phase II trial with time-to-event outcome using the concept of relative time in the case of non-proportional hazards;Journal of Biopharmaceutical Statistics;2023-08-14